Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar;34(2):236-243.
doi: 10.1111/pcmr.12949. Epub 2020 Dec 15.

An update on Vitiligo pathogenesis

Julien Seneschal  1   2 , Katia Boniface  1 , Andrea D'Arino  3 , Mauro Picardo  3
Affiliations
Review

An update on Vitiligo pathogenesis

Julien Seneschal et al. Pigment Cell Melanoma Res. 2021 Mar.

Abstract

Vitiligo, the most common depigmenting disorder of the skin, is undergoing a period of intense advances in both disease understanding and therapeutic possibilities leading the way to the beginning of a new era for the disorder. Its pathophysiology has gathered the attention of researchers for years, and many advances have been made in the clarification of the interaction between different factors that result in depigmented macule formation. The complex interplay between non-immunological and immunological factors in vitiligo is key for the development of the disease, and the participation of cells other than melanocytes, such as keratinocytes, fibroblasts, natural killer cells, and innate lymphoid cells, has been shown. Recent advances have also brought to the understanding of the complex part played by a specific subtype of T cells: T-resident memory cells. This review analyzes some of the most recent insights in vitiligo pathogenesis underlining the interactions between different cell types, which are the basis for the therapeutic approaches under development.

Keywords: IFN-gamma; cell-cell cross talk; fibroblasts; immunopathogenesis; keratinocytes; memory T cells.

PubMed Disclaimer

References

REFERENCES

    1. Abdallah, M., El-Mofty, M., Anbar, T., Rasheed, H., Esmat, S., Al-Tawdy, A., Fawzy, M. M., Abdel-Halim, D., Hegazy, R., Gawdat, H., Bassiouny, D., Ibrahim, M. A., Sany, I., El-Bassiouny, M., Khalil, M., Abdel-Aziz, A., El Maadawi, Z. M., & Mostafa, W. Z. (2018). CXCL-10 and Interleukin-6 are reliable serum markers for vitiligo activity: A multicenter cross-sectional study. Pigment Cell. Melanoma Res., 31, 330-336. https://doi.org/10.1111/pcmr.12667
    1. Ahn, Y., Seo, J., Lee, E. J., Kim, J. Y., Park, M. Y., Hwang, S., Almurayshid, A., Lim, B. J., Yu, J. W., & Oh, S. H. (2020). ATP-P2X7-induced inflammasome activation contributes to melanocyte death and CD8(+) T cell trafficking to the skin in vitiligo. The Journal of Investigative Dermatology, 140, 1794-1804.e4. https://doi.org/10.1016/j.jid.2019.12.035
    1. Azzolino, V., Zapata, L. Jr, Garg, M., Gjoni, M., Riding, R. L., Strassner, J. P., Richmond, J. M., & Harris, J. E. (2020). Jak inhibitors reverse vitiligo in mice but do not deplete skin resident memory T cells. Journal of Investigative Dermatology, https://doi.org/10.1016/j.jid.2020.04.027
    1. Bartel, D. P. (2018). Metazoan microRNAs. Cell, 173, 20-51. https://doi.org/10.1016/j.cell.2018.03.006
    1. Bastonini, E., Bellei, B., Filoni, A., Kovacs, D., Iacovelli, P., & Picardo, M. (2019). Involvement of non-melanocytic skin cells in vitiligo. Experimental Dermatology, 28, 667-673. https://doi.org/10.1111/exd.13868

LinkOut - more resources